CrossFirst Announces Details of Fourth Quarter and Full Year 2020 Earnings Results, Webcast and Conference Call Nasdaq:CFB


(MENAFN- GlobeNewsWire - Nasdaq) LEAWOOD, Kan., Jan. 05, 2021 (GLOBE NEWSWIRE) -- CrossFirst Bankshares, Inc. (Nasdaq: CFB) will release its fourth quarter and full year 2020 results on Thursday, January 28, 2021, with a press release issued after market close.

CrossFirst's management team will hold a conference call and webcast to discuss fourth quarter and full year 2020 results on Thursday, January 28, 2021 at 4 p.m. Central time / 5 p.m. Eastern time.

Investors, news media, and other participants should register for the call or audio webcast at https://investors.crossfirstbankshares.com, participants may dial into the call toll-free at (877) 621-5851 from anywhere in the U.S. or (470) 495-9492 internationally, using conference ID no. 8838529. Participants are encouraged to dial into the call or access the webcast approximately 10 minutes prior to the start time.

A replay of the webcast will be available on the company website. A replay of the conference call will be available two hours following the close of the call until February 4, 2021, accessible at (855) 859-2056 with conference ID no. 8838529.

ABOUT CROSSFIRST

CrossFirst Bankshares, Inc. (Nasdaq: CFB) is a Kansas corporation and a registered bank holding company for its wholly-owned subsidiary CrossFirst Bank, which is headquartered in Leawood, Kansas. CrossFirst Bank has eight full-service banking offices primarily along the I-35 corridor in Kansas, Missouri, Oklahoma and Texas.

Investor Relations/Media Contact:
Matt Needham
CrossFirst Bankshares, Inc.
913-312-6822


MENAFN05012021004107003653ID1101390296


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.